Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies - Additional Information (Details)

v3.24.2.u1
Basis of Presentation and Significant Accounting Policies - Additional Information (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Summary Of Significant Accounting Policies [Line Items]          
Common stock, par value $ 0.001   $ 0.001   $ 0.001
Revenue $ 0   $ 0    
Reverse stock split description     On June 30, 2023, we effected a reverse stock split at the ratio of 1 post-split share for every 6 pre-split shares.    
Research and Development Expense 3,075,830   $ 5,827,109    
Minimum | Office Equipment          
Summary Of Significant Accounting Policies [Line Items]          
Estimated Useful Lives     three    
Maximum | Office Equipment          
Summary Of Significant Accounting Policies [Line Items]          
Estimated Useful Lives     five    
Vendor [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Research and Development Expense $ 175,000   $ 297,000    
Payable balance to vendor     $ 125,000   $ 57,000
Customer Concentration Risk | Sales Revenue          
Summary Of Significant Accounting Policies [Line Items]          
Concentration risk, percentage   100.00%   100.00%